Categorization and labeling systems concerning driving-impairing medicines: A scoping review

References

• Alvarez FJ. 2016. Parkinson’s disease, antiparkinson medicines, and driving. Expert Rev Neurother. 16(9):1023–1032. doi:10.1080/14737175.2016.1218278.
   PubMed Web of Science ®Google Scholar
• Álvarez González FJ, Gómez Talegón T, Fierro Lorenzo MI. 2011. Establishment of framework for classification/categorisation and labelling of medicinal drugs and driving (DRUID Deliverable 4.3); [accessed 2011 Oct 14]. https://www.bast.de/Druid/EN/deliverales-list/deliverables-list-node.html.
   Google Scholar
• Atchison L. 2017. Preventing drug driving in Europe: policy measures for national and EU action. Belgium: European Transport Safety Council (ETSC); [accessed 2017 March]. http://etsc.eu/preventing-drug-driving-in-europe/.
   Google Scholar
• Del Río MC, Alvarez FJ. 2003. Medication and fitness to drive. Pharmacoepidemiol Drug Saf. 12(5):389–394. doi:10.1002/pds.806.
   PubMed Web of Science ®Google Scholar
• DRUID. 2011. Driving under the Influence of Drugs, Alcohol and Medicines; [accessed 2011 Oct]. https://www.bast.de/Druid/EN/Home/home_node.html.
   Google Scholar
• Emich B, Van Dijk L, Monteiro SP, De Gier JJ. 2015. A study comparing the effectiveness of three warning labels on the package of driving-impairing medicines. Int J Clin Pharm. 37(1):200. doi:10.1007/s11096-014-0039-2.
   Google Scholar
• Fierro I, Gomez-Talegon T, Alvarez FJ. 2013. The Spanish pictogram on medicines and driving: the population’s comprehension of and attitudes towards its use on medication packaging. Accid Anal Prev. 50:1056–1061. doi:10.1016/j.aap.2012.08.009.
   PubMed Web of Science ®Google Scholar
• Fukuda Y, Ando S, Saito M. 2020. Effect of a Japanese drug alert pictogram on medication-taking/driving behavior. Traffic Inj Prev. 21(1):18–23. doi:10.1080/15389588.2019.1680838.
   PubMed Web of Science ®Google Scholar
• de Gier JJ, Ravera S, Monteiro SP, Alvarez FJ. 2011. Establishment of criteria for a European categorisation system for medicines and driving (DRUID deliverable 4.2.1); [accessed 2011 Oct 05]. https://www.bast.de/Druid/EN/deliverales-list/deliverables-list-node.html.
   Google Scholar
• Karjalainen K, Lintonen T. 2017. DUI offenders may have multiple health and social problems-doctors play a central role in monitoring the use of medications affecting the central nervous system. Duodecim. 133(10):927–934.
   PubMedGoogle Scholar
• Klipp S. 2009. EU DRUID project: results of a Questionnaire Survey amongst participants of driver rehabilitation programmes in Europe. Eur Transp Res Rev. 1(4):185–198. doi:10.1007/s12544-009-0019-0.
   Google Scholar
• Leproust S, Lagarde E, Salmi LR. 2008. Systematic screening for unsafe driving due to medical conditions: still debatable. BMC Public Health. 8(1):27. doi:10.1186/1471-2458-8-27.
   PubMedGoogle Scholar
• Marillier M, Verstraete AG. 2019. Driving under the influence of drugs. Wiley Interdiscip Rev: Forensic Sci. 1(3):e1326. doi:10.1002/wfs2.1326.
   Google Scholar
• Monteiro SP, Huiskes R, Dijk L, Van Weert JCM, de Gier JJ. 2013. How effective are pictograms in communicating risk about driving-impairing medicines? Traffic Inj Prev. 14(3):299–308. doi:10.1080/15389588.2012.710766.
   PubMed Web of Science ®Google Scholar
• Monteiro SP, van Dijk L, Verstraete AG, Álvarez FJ, Heissing M, De Gier JJ. 2012. Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: a multi-country survey. BMC Public Health. 12(1):59. doi:10.1186/1471-2458-12-59.
   PubMedGoogle Scholar
• Orriols L, Delorme B, Gadegbeku B, Tricotel A, Contrand B, Laumon B, Salmi LR, Lagarde E, On Behalf of the CESIR Research Group. 2010. Prescription medicines and the risk of road traffic crashes: a French registry-based study. PLoS Med. 7(11):e1000366. doi:10.1371/journal.pmed.1000366.
   PubMed Web of Science ®Google Scholar
• Orriols L, Luxcey A, Contrand B, Gadegbeku B, Delorme B, Tricotel A, Moore N, Salmi L, Lagarde E. 2016. Road traffic crash risk associated with benzodiazepine and z-hypnotic use after implementation of a colour-graded pictogram: a responsibility study. Br J Clin Pharmacol. 82(6):1625–1635. doi:10.1111/bcp.13075.
   PubMedGoogle Scholar
• Pil K, Raes E, Van den Neste T, Goessaert A, Veramme J, Verstraete A. 2008. Review of existing classification efforts (Deliverable 4.1.1); [accessed 2008 May 15]. https://www.bast.de/Druid/EN/deliverales-list/deliverables-list-node.html.
   Google Scholar
• Pollini RA, Waehrer G, Kelley-Baker T. 2017. Receipt of warnings regarding potentially impairing prescription medications and associated risk perceptions in a national sample of U.S. drivers. J Stud Alcohol Drugs. 78(6):805–813. doi:10.15288/jsad.2017.78.805.
   PubMedGoogle Scholar
• Ravera S, Monteiro SP, de Gier JJ, van der Linden T, Gómez-Talegón T, Álvarez FJ, Pil K, Verstraete A, Mallaret M, Charles MG, DRUID Project WP4 Partners, et al. 2012. A European approach to categorizing medicines for fitness to drive: outcomes of the DRUID project. Br J Clin Pharmacol. 74(6):920–931. doi:10.1111/j.1365-2125.2012.04279.x.
   PubMed Web of Science ®Google Scholar
• Redelmeier DA, Tien HC. 2014. Medical interventions to reduce motor vehicle collisions. CMAJ. 186(2):118–124. doi:10.1503/cmaj.122001.
   PubMed Web of Science ®Google Scholar
• Redelmeier DA, Yarnell CJ, Thiruchelvam D, Tibshirani RJ. 2012. Physicians’ warnings for unfit drivers and the risk of trauma from road crashes. N Engl J Med. 367(13):1228–1236. doi:10.1056/NEJMsa1114310.
   PubMed Web of Science ®Google Scholar
• Smyth T, Sheehan M, Siskind V. 2011. A study of the effectiveness of driving medication warnings.
   Google Scholar
• Smyth T, Sheehan M, Siskind V, Mercier-Guyon C, Mallaret M. 2013. Consumer perceptions of medication warnings about driving: a comparison of French and Australian labels. Traffic Inj Prev. 14(6):557–564. doi:10.1080/15389588.2012.729278.
   PubMed Web of Science ®Google Scholar
• Stelter RL, Kupersmidt JB, Brodar K, Eisensmith S. 2019. The prevention of drugged driving: needs, barriers, and self-efficacy of prevention professionals. J Prim Prev. 40(4):449–461. doi:10.1007/s10935-019-00555-2.
   PubMed Web of Science ®Google Scholar
• Strand MC, Mørland J, Slørdal L, Riedel B, Innerdal C, Aamo T, Mathisrud G, Vindenes V. 2017. Conversion factors for assessment of driving impairment after exposure to multiple benzodiazepines/z-hypnotics or opioids. Forensic Sci Int. 281:29–36. doi:10.1016/j.forsciint.2017.10.022.
   PubMed Web of Science ®Google Scholar
• van der Sluiszen NN, Vermeeren A, Jongen S, Vinckenbosch F, Ramaekers JG. 2017. Influence of long-term benzodiazepine use on neurocognitive skills related to driving performance in patient populations: a review. Pharmacopsychiatry. 50(5):189–196. doi:10.1055/s-0043-112755.
   PubMed Web of Science ®Google Scholar
• Veldhuijzen DS, van Wijck AJ, Verster JC, Kalkman CJ, Kenemans JL, Olivier B, Volkerts E. 2006. The impact of chronic pain patients’ psychotropic drug knowledge and warning labels on the decision whether to drive a car or not. Traffic Inj Prev. 7(4):360–364. doi:10.1080/15389580600943005.
   PubMedGoogle Scholar
• Verster JC, Mets MAJ. 2009. Psychoactive medication and traffic safety. Int J Environ Res Public Health. 6(3):1041–1054. doi:10.3390/ijerph6031041.
   PubMed Web of Science ®Google Scholar
• Vindenes V, Boix F, Koksaeter P, Strand MC, Bachs L, Mørland J, Gjerde H. 2014. Drugged driving arrests in Norway before and after the implementation of per se law. Forensic Sci Int. 245:171–177. doi:10.1016/j.forsciint.2014.10.038.
   PubMed Web of Science ®Google Scholar
• Wolff K. 2017. Different approaches to setting limits for drugs and alcohol use when driving. In The SAGE handbook of drug and alcohol studies. London: Sage. p. 435–446. doi:10.1080/09687637.2017.1344620.
   Google Scholar
• Wolschrijn H, Gier JJ, Smet PAGM. 1991. Drugs & driving: new categorization system for drugs affecting psychomotor performance: institute for drugs, safety and behavior. Tech Report. The Netherlands: University of Limburg.
   Google Scholar
• World Health Organization. 2018. Global status report on road safety 2018. [accessed 2018].
   Google Scholar